Jun 19

Introducing NeuroMind AI

Press Release

For Immediate Release

NeuroMind™ Academy Unveils World's First AI-Supported Accredited Continuous Medical Education Program

Revolutionizing Medical Education with NeuroMind™ AI (Patent-Pending)

Maastricht, June 19, 2024 – NeuroMind™ Academy is proud  to announce the launch of the world’s first AI-supported accredited Continuous Medical Education (CME) program, marking a significant milestone in medical education. This pioneering program leverages artificial intelligence to provide medical proffesionals with personalized and innovative educational content  worldwide.

Introducing NeuroMind™ AI: Personalized Training for Medical Professionals

NeuroMind™ Academy was launched in 2023 to enhance doctors' decision-making capabilities by increasing their digital literacy in artificial intelligence, machine learning, and large language models. In 2024, NeuroMind™ Academy took a groundbreaking step forward with the development of NeuroMind™ AI. This innovative tool combines trusted medical resources with large language models to create personalized training for doctors. The first demonstration of this is in the new and accredited e-learning material, "Digital Medicine: AI, Machine Learning and Large Language Models in Healthcare," available at https://neuromind.academy.

Cooperation with Maastricht University

NeuroMind™ Academy is proud to highlight its strong cooperation with Maastricht University in supporting medical professionals in knowledge management. This collaboration led developing  a patent-pending algorithm that optimizes content for large language model processing, resulting in better and more detailed educational output. This partnership underscores our commitment to leveraging innovative technology to improve medical education and outcomes.

Commitment to Climate Protection

Currently, scientific conferences are responsible for more than 1 billion kg of carbon emissions annually, equivalent to the impact of fifty million trees. Despite the availability of online CME, travel-related emissions account for 98% of this total. NeuroMind™ Academy is committed to making online CME fit the needs and preferences of individual healthcare providers, offering a superior learning experience while significantly reducing travel-related carbon emissions in the medical-scientific community.

Accredited and Recognized

The e-learning materials offered by NeuroMind™ Academy are accredited by the European Accreditation Council for Continuing Medical Education (EACCME®). Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians can convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. For professionals in other countries, please contact the relevant national or regional accreditation authority.

About Us

NeuroMind™ has been the leading app for neurosurgical decision support since its first release in 2010, serving more than 15,000 neurosurgeons worldwide. Our goal is to be at the forefront of medical knowledge innovation, dedicated to improving healthcare outcomes through advanced technology and education. Our mission is to empower medical professionals with the knowledge and tools they need to make better decisions and provide superior patient care.

Future

NeuroMind™ Academy plants to expand its offerings with new courses to reach a broader group of medical professionals and policymakers in healthcare. This to support them with information on the latest developments in their field. This through AI and machine learning.  

Contact / Information:

Pieter Kubben, MD, PhDhttps://neuromind.academy
pieter@decisix.nl
 


Media Contact:

info@decisix.nl 


For further information, please visit https://neuromind.academy.

 

End of Release